TipRanks
Henry Schein (HSIC)
NASDAQ:HSIC
US Market
Want to see HSIC full AI Analyst Report?

Henry Schein (HSIC) Blogger Opinions & Sentiment

418 Followers

Blogger Sentiment

Bullish: 83.33%
Sector Average
Bullish
HSIC Blogger sentiment is based on 6 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% SeekingAlpha
33% Zacks
17% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Mario Cibelli's Top Q2 2026 Move: Genuine Parts Co at a 3.03% Portfolio Impact
GuruFocus
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Why Henry Schein HSIC Is a Top Momentum Stock for the Long-Term
Zacks
Henry Schein Still Gives Me A Reason To Smile After This Nice Move Higher
SeekingAlpha
Henry Schein: Growth Is Improving, But The Valuation Stays Cheap
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of HSIC?
Seeking Alpha’s Daniel Jones has a Bullish Sentiment.
    What do Motley Fool contributors think of HSIC?
    Currently there's no blogger sentiment for HSIC.
    What Is HSIC’s Blogger Sentiment?
    HSIC’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for HSIC?
      The most recent blogger prediction for HSIC was made by Zacks Equity Research, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          HCAHCA Healthcare
          ABTAbbott Laboratories
          ARGXArgenx Se
          PRNAFAlterity Therapeutics
          VRTXVertex Pharmaceuticals